Head-to-head Dota 2 7.41f win rate from ranked matches.
In Dota 2 7.41f, Nyx Assassin wins the Crystal Maiden vs Nyx Assassin matchup: Nyx Assassin beats Crystal Maiden in 51.51% of 41,420 ranked matches.
Using Spiked Carapace to reflect Frostbite or instantly cancel Freezing Field gives Nyx Assassin a huge advantage in a direct confrontation. He's built to find and eliminate fragile supports, and Crystal Maiden is a primary target. The matchup hinges on positioning and vision control. If Nyx finds her alone, she has few ways to survive his burst combo. However, a prepared Crystal Maiden can turn the tables. With good warding and by staying near her allies, she can use her root to lock down an aggressive Nyx Assassin for an easy counter-kill. It becomes a classic cat-and-mouse game where the outcome depends entirely on which hero gets the jump.
How the matchup shifts across skill brackets — Crystal Maiden's win rate against Nyx Assassin in recent ranked matches, split by average match rank. Ranks with too few recent matches are omitted. These rows use the last 30 days of quality-filtered ranked matches, all patches in that span combined — a wider window than the patch-scoped count above, so the per-rank match totals can exceed it.
| Rank | Crystal Maiden win rate | Matches |
|---|---|---|
| Herald & Guardian | 52.48% | 343 |
| Crusader & Archon | 50.12% | 1,267 |
| Legend & Ancient | 47.82% | 1,399 |
| Divine & Immortal | 43.58% | 374 |
Crystal Maiden's win rate against Nyx Assassin in each recent balance patch — whether this matchup is trending up or down. Patches without enough matches are omitted.
| Patch | Crystal Maiden win rate | Change | Matches |
|---|---|---|---|
| 7.41f | 48.49% | ▼ -0.6pp | 41,420 |
| 7.41e | 49.06% | ▼ -0.1pp | 124,009 |
| 7.41d | 49.13% | ▲ +0.2pp | 138,643 |
| 7.41c | 48.98% | — | 56,718 |
Move this data into a draft
Crystal Maiden starts on Radiant and Nyx Assassin on Dire. Add the other eight picks to see whether this head-to-head edge survives the full draft.
Data updated Oct 4, 2026.